Silencing of DHX9 reversed the apoptotic resistance of LINC01016-overexpressing BC cells, suggesting that LINC01016 enhanced BC cell pathogenicity in a DHX9-dependent manner. This evidence concerns the gene LINC01016 and breast cancer.